Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5063606

Nc1nonc1-c1nc2c(-c3ccccc3)ncc(C(=O)N3CCC(N)C3)c2n1-c1ccc(F)cc1.O=C(O)C(F)(F)F

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC2A1 P11166 1/20 0.60
ROCK1 Q13464 8/20 0.46
AKT1 P31749 7/20 0.46
RPS6KA5 O75582 6/20 0.46
AKT2 P31751 5/20 0.46
RPS6KA1 Q15418 5/20 0.46
AKT3 Q9Y243 4/20 0.46
ROCK2 O75116 2/20 0.46
GSK3A P49840 2/20 0.46
PRKACA P17612 2/20 0.46
GSK3B P49841 2/20 0.46
DAPK3 O43293 1/20 0.46
PRKD3 O94806 1/20 0.46
PIM1 P11309 1/20 0.46
MARK3 P27448 1/20 0.46
GRK5 P34947 1/20 0.46
CDK8 P49336 1/20 0.46
CLK2 P49760 1/20 0.46
CDK7 P50613 1/20 0.46
RPS6KA3 P51812 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4070906 0.96 SLC2A1 (0.55) SLC2A1ROCK1AKT1RPS6KA5AKT2
Trifluoroacetic Acid SCHEMBL5063586 0.95 SLC2A1 (0.61) SLC2A1ROCK1AKT1RPS6KA5AKT2
SCHEMBL5062971 0.91 SLC2A1 (0.54) SLC2A1ROCK1AKT1RPS6KA5AKT2
Trifluoroacetic Acid SCHEMBL5066186 0.87 SLC2A1 (0.61) SLC2A1ROCK1AKT1RPS6KA5AKT2
Trifluoroacetic Acid SCHEMBL5067532 0.86 SLC2A1 (0.65) SLC2A1ROCK1AKT1RPS6KA5AKT2
Trifluoroacetic Acid SCHEMBL5063651 0.84 SLC2A1 (0.77) SLC2A1ROCK1AKT1RPS6KA5AKT2
SCHEMBL4063413 0.83 SLC2A1 (0.59) SLC2A1ROCK1AKT1RPS6KA5AKT2
SCHEMBL5063564 0.82 SLC2A1 (0.55) SLC2A1ROCK1AKT1RPS6KA5AKT2
Hydrochloric Acid SCHEMBL5062470 0.82 SLC2A1 (0.58) SLC2A1ROCK1AKT1RPS6KA5AKT2
Trifluoroacetic Acid SCHEMBL5058540 0.81 SLC2A1 (0.74) SLC2A1ROCK1AKT1RPS6KA5AKT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080255143-A1 Inhibitors of Akt Activity SMITHKLINE BEECHAM CORPORATION (PA) 2008-10-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080255143-A1 Inhibitors of Akt Activity PI4KB, PIK3CA, AKT2 SLC2A1 3039/4885ROCK1 478/4885AKT1 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.